Singota Solutions

Singota Solutions

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $14.5M

Overview

Singota Solutions is a specialized CDMO focused on accelerating early-phase injectable drug development and manufacturing. It differentiates itself through a flexible, single-site model, proprietary gloveless robotic aseptic filling technology (SA25), and comprehensive service integration from development through cold chain storage. The company targets pharmaceutical, biotech, and animal health clients seeking speed and reliability for small-batch clinical trial materials. Its strategy is built on technological innovation, operational excellence, and a collaborative project management structure.

Drug Delivery

Technology Platform

Gloveless, robotic SA25 Aseptic Filling system for small-batch parenterals, integrated with GMP analytical labs and cold chain supply chain management.

Funding History

2
Total raised:$14.5M
Series A$12M
Seed$2.5M

Opportunities

Growing demand for outsourced small-batch manufacturing from virtual/small biotechs and for complex injectables (e.g., biologics, mRNA).
Expansion of cold chain supply chain services into Europe provides a new geographic revenue stream.
The first-mover advantage with the SA25 robotic filler positions the company as a leader in high-quality, low-risk aseptic processing.

Risk Factors

Revenue is highly dependent on the funding and clinical success of client biotech companies, making it susceptible to industry downturns.
A single significant sterility failure or regulatory compliance issue could catastrophically damage its reputation built on quality.
Intense competition from other CDMOs requires continuous innovation and investment to maintain its technological edge.

Competitive Landscape

Singota competes in the injectables CDMO space against large global players (e.g., Lonza, Catalent) and smaller niche providers. Its primary differentiation is the combination of specialized small-batch focus, proprietary robotic aseptic filling (SA25), and integrated, agile service from a single site. Competition is based on technology, speed, quality, reliability, and price.